Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma

by Arissa C Young, Henry T Quach, Haocan Song, Javid J Moslehi
Published 2020-07-01

Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis

by MacRae F. Linton, Javid J. Moslehi, Vladimir R. Babaev
Published 2019-06-01

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients

by Mandar A. Aras, MD, PhD, John R. Power, MD, Javid J. Moslehi, MD
Published 2020-09-01

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

by Douglas B. Johnson, Ali Manouchehri, Alexandra M. Haugh, Henry T. Quach, Justin M. Balko, Benedicte Lebrun-Vignes, Andrew Mammen, Javid J. Moslehi, Joe-Elie Salem
Published 2019-05-01

Smoldering myocarditis following immune checkpoint blockade

by Timothy G. Norwood, Brian C. Westbrook, Douglas B. Johnson, Silvio H. Litovsky, Nina L. Terry, Svetlana B. McKee, Alan S. Gertler, Javid J. Moslehi, Robert M. Conry
Published 2017-11-01

High Sensitivity Troponin T and NT-proBNP in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy

by Jiun-Ruey Hu, Ameet Patel, Shi Huang, Yan Ru Su, Kimberly B. Dahlman, Kelsey Tomasek, Yueli Zhang, Richard T. O’Neil, Jamye F. O’Neal, Isik Turker, Douglas B. Johnson, Joe-Elie Salem, Javid J. Moslehi, Olalekan Oluwole
Published 2021-08-01